Intellia is instituting new safeguards following the death of a study participant that led regulators to pause two trials in ...

Americans who smoke may soon be hearing a lot more about Zyn. That's the flavored nicotine pouch that's generated billions in ...

Flavored nicotine pouches called Zyn could soon be legally advertised as a lower-risk option for adults who smoke, as federal ...

Please provide your email address to receive an email when new articles are posted on . The device is the first to gain FDA clearance to monitor delirium. The device’s algorithm was validated with ...

Please provide your email address to receive an email when new articles are posted on . The FDA issued a complete response letter for relacorilant to treat hypertension tied to hypercortisolism. The ...

The Food and Drug Administration has continued its pharma ad crackdown by issuing a pair of new Untitled Letters and releasing a series of close-out letters indicating drugmakers have made changes to ...

Echoing President Donald Trump’s call to accelerate medical innovation, Food and Drug Administration (FDA) Commissioner Marty Makary announced that the agency will no longer block companies from ...

The U.S. Food and Drug Administration (FDA) is weighing a change that could make warning labels on dietary supplements appear less often on packaging. Unlike prescription drugs, dietary supplements ...

FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned 32-subject clinical trial ESTERO, FL / ACCESS Newswire / January 7, 2026 / Aspire Biopharma ...